1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Mucocutaneous Lymph Node Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, G; Ohtani, N | 1 |
| Holland, PC; Levin, M; Novelli, V | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Mucocutaneous Lymph Node Syndrome
| Article | Year |
|---|---|
[Purification and partial characterization of a novel human platelet aggregation factor in the extracellular products of Streptococcus mitis, strain Nm-65].
Topics: Animals; Blood Platelets; Chromatography; Dinoprostone; Electrophoresis, Polyacrylamide Gel; Female; Humans; Male; Mucocutaneous Lymph Node Syndrome; Platelet Activating Factor; Platelet Aggregation; Rabbits; Streptococcus | 1996 |
Platelet immune complex interaction in the pathogenesis of Kawasaki disease.
Topics: Antigen-Antibody Complex; Blood Coagulation Factors; Child; Child, Preschool; Humans; Immunoglobulin G; Mucocutaneous Lymph Node Syndrome; Platelet Activating Factor; Platelet Aggregation; Thrombocytosis | 1987 |